Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Canadian Prospective Pragmatic Perilunate Outcomes Trial (The C3PO Trial)

NCT04370626 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT04370626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04370626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Canadian Prospective Pragmatic Perilunate Outcomes Trial (The C3PO Trial)
Lead sponsor
University of Calgary
Phase
Observational
Overall status
Recruiting
Start date
September 1, 2020
Completion date
December 31, 2026
Enrollment
450 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carpal bone fracture, dislocation of wrist, trauma, wrist injuries